- Parkinson's disease etiology and experimental therapeutics
- Developmental neurotoxicology of drugs of abuse
- Fetal dopamine neuron development
- +۵ مورد دیگر
Jack W. Lipton , PhD, serves as Chair and Professor of Translational Neuroscience at Michigan State University's College of Human Medicine. He directs the Lipton Lab at the Grand Rapids Research Center and holds a joint appointment with the MSU Neuroscience Program. Education: UC Berkeley (B.A. Psychology), UCLA (Ph.D. Behavioral Neuroscience) Prior institutions: Rush University Medical Center, University of Cincinnati Dr. Lipton's research spans two major domains: neurodegenerative disease and developmental neurotoxicology . His Parkinson's disease work focuses on: Alpha-synuclein pathology Gene therapy approaches Deep brain stimulation Neural transplantation Developmental studies examine: MDMA/cocaine effects on fetal dopamine neurons Neurite sprouting mechanisms Behavioral consequences of prenatal exposure Long-term CNS changes from drugs of abuse Key funding sources include: NIH (continuous since 1993) National Institute on Drug Abuse National Institute on Neurological Disorders Michael J. Fox Foundation Recent publications demonstrate expertise in: Alpha-synuclein fibril modeling Saliva-based diagnostics Neurotrophic factor genetics Aged animal model systems Scientific leadership includes: Director, Division of Neuropharmacology (UC 2004-2009) Founder, MSU Department of Translational Neuroscience Director, MSU Early Detection Program Chair, MSU Translational Science and Molecular Medicine Current initiatives focus on: Biomedical disaster preparedness University research analytics Saliva testing infrastructure Translational science leadership






